Unlock full lesson + practice questions
13 more sections with scenarios, priorities, and review drills.
Topic overview
Explain mTOR inhibitor mechanism for sirolimus and everolimus Clinical framing, safety cues, prioritization patterns, and exam-style rationale for Transplant Immunosuppression: Mtor Inhibitors, Cytotoxic Agents.
Clinical reasoning
For Transplant Immunosuppression: Mtor Inhibitors, Cytotoxic Agents, connect the assessment cue to the immediate risk before selecting an action for NP. Start with stability, ABCs, neurologic change, medication risk, infection risk, and scope of practice. Then decide whether the safest next step is assess, intervene, escalate, teach, or evaluate response.
Patient safety implications
A missed priority in Transplant Immunosuppression: Mtor Inhibitors, Cytotoxic Agents can delay recognition of deterioration or allow preventable harm to continue. Protect the client first by verifying abnormal cues, using ordered precautions, escalating unstable findings, and reassessing after intervention.
Example application
In a Transplant Immunosuppression: Mtor Inhibitors, Cytotoxic Agents item, explain the first cue you noticed, the complication it predicts, the nursing action within scope, and the finding that proves the response worked.
Next study step
Continue Your Learning
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Review FlashcardsPractice Related QuestionsContinue Weak Area RecoveryRecommended Next LessonTake A Readiness Quiz
Learning ContextWhat should I do next?
Practice FundamentalsRetest from the same lesson context and competency.Sign in to save progress on this lesson.